Enhancement of Small Particle Size Dry Powder Aerosol Formulations Using an Ultra Low Density Additive
Overview
Authors
Affiliations
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.
Salustio P, Amaral M, Costa P J Aerosol Med Pulm Drug Deliv. 2024; 37(6):307-327.
PMID: 39120712 PMC: 11669763. DOI: 10.1089/jamp.2023.0029.
Poly(malic acid)-budesonide nanoconjugates embedded in microparticles for lung administration.
Tessier B, Moine L, Peramo A, Tsapis N, Fattal E Drug Deliv Transl Res. 2024; 14(8):2062-2078.
PMID: 38517568 DOI: 10.1007/s13346-024-01571-4.
Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs.
Garcia-Contreras L, Padilla-Carlin D, Sung J, VerBerkmoes J, Muttil P, Elbert K J Pharm Sci. 2016; 106(1):331-337.
PMID: 27842973 PMC: 5637532. DOI: 10.1016/j.xphs.2016.09.033.
Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer.
Singh D, Lohade A, Parmar J, Hegde D, Soni P, Samad A Indian J Pharm Sci. 2013; 74(6):521-6.
PMID: 23798777 PMC: 3687921. DOI: 10.4103/0250-474X.110584.
Tuli R, George G, Dargaville T, Islam N Pharm Res. 2012; 29(9):2445-55.
PMID: 22584947 DOI: 10.1007/s11095-012-0772-y.